|
ZTS's Net Income Growth by Quarter and Year
Zoetis Inc 's Net Income results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| ZTS Net Income (in millions $) |
FY 2024 |
FY 2023 |
FY 2022 |
FY 2021 |
| IV Quarter |
December |
-
|
523.00
|
460.00
|
413.00
|
| III Quarter |
September |
-
|
596.00
|
528.00
|
552.00
|
| II Quarter |
June |
624.00
|
670.00
|
529.00
|
511.00
|
| I Quarter |
March |
599.00
|
551.00
|
594.00
|
558.00
|
| FY |
|
1,223.00
|
2,340.00
|
2,111.00
|
2,034.00
|
| ZTS Net Income second quarter 2024 Y/Y Growth Comment |
Zoetis Inc reported decrease in Net Income in the second quarter 2024 by -6.87% to $ 624.00 millions, from the same quarter in 2023.
The decrease in the second quarter 2024 Zoetis Inc 's Net Income compares unfavorably to the Company's average Net Income rise of 21.83%.
Looking into second quarter 2024 results within Major Pharmaceutical Preparations industry 11 other companies have achieved higher Net Income growth. While Zoetis Inc ' s Net Income decline of -6.87% ranks overall at the positon no. 611 in the second quarter 2024.
|
| ZTS Net Income ( Y/Y Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
December |
- |
13.7 % |
11.38 % |
15.36 % |
| III Quarter |
September |
- |
12.88 % |
-4.35 % |
15.24 % |
| II Quarter |
June |
-6.87 % |
26.65 % |
3.52 % |
35.9 % |
| I Quarter |
March |
8.71 % |
-7.24 % |
6.45 % |
31.91 % |
| FY |
|
- |
10.85 % |
3.79 % |
24.33 % |
ZTS Net Income (Quarter on Quarter Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
December |
- |
-12.25 % |
-12.88 % |
-25.18 % |
| III Quarter |
September |
- |
-11.04 % |
-0.19 % |
8.02 % |
| II Quarter |
June |
4.17 % |
21.6 % |
-10.94 % |
-8.42 % |
| I Quarter |
March |
14.53 % |
19.78 % |
43.83 % |
55.87 % |
| FY (Year on Year) |
|
- |
10.85 % |
3.79 % |
24.33 % |
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 141.59 % |
21.83 % |
-42.25 % |
| (Dec 31 2016) |
|
(Dec. 30, 2015) |
|
|
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 141.59 % |
21.83 % |
-42.25 % |
| (Dec 31 2016) |
|
(Dec. 30, 2015) |
|
| Net Income by Quarter for the Fiscal Years 2021, 2022, 2023, 2024 |
Zoetis Inc 's Q/Q Net Income Growth
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 920 % |
30.18 % |
-89.47 % |
| (Apr 03 2016) |
|
|
| ZTS's II. Quarter Q/Q Net Income Comment |
Zoetis Inc achieved in the II. Quarter 2024 below company average Net Income growth of 4.17% quarter on quarter, to $ 624.00 millions.
Within Major Pharmaceutical Preparations industry 9 other companies have achieved higher Net Income quarter on quarter growth. While Zoetis Inc 's Net Income growth quarter on quarter, overall rank is 768. |
|
|
|
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 920 % |
30.18 % |
-89.47 % |
| (Apr 03 2016) |
|
|
| ZTS's II. Quarter Q/Q Net Income Comment |
Zoetis Inc achieved in the II. Quarter 2024 below company average Net Income growth of 4.17% quarter on quarter, to $ 624.00 millions.
Within Major Pharmaceutical Preparations industry 9 other companies have achieved higher Net Income quarter on quarter growth. While Zoetis Inc 's Net Income growth quarter on quarter, overall rank is 768. |
|
Zoetis Inc 's 12 Months Net Income Growth Year on Year
Net Income TTM Growth |
12 Months Ending
(Jun 30 2024) |
12 Months Ending
(Mar 31 2024) |
12 Months Ending
(Dec 31 2023) |
12 Months Ending
(Sep 30 2023) |
12 Months Ending
(Jun 30 2023) |
| Cumulative Net Income 12 Months Ending |
$ 2,342.00 |
$ 2,388.00 |
$ 2,340.00 |
$ 2,277.00 |
$ 2,209.00 |
| Y / Y Net Income Growth (TTM) |
6.02 % |
15.47 % |
10.85 % |
10.32 % |
5.8 % |
| Year on Year Net Income Growth Overall
Ranking |
# 620 |
# 339 |
# 291 |
# 322 |
# 733 |
| Seqeuential Net Income Change (TTM) |
-1.93 % |
2.05 % |
2.77 % |
3.08 % |
6.82 % |
| Seq. Net Income Growth (TTM) Overall
Ranking |
# 611 |
# 350 |
# 304 |
# 363 |
# 898 |
| Cumulative Net Income growth
Comment |
With the quarterly Net Income reported in the Jun 30 2024 period, Zoetis Inc 's cumulative twelve months Net Income were $ 2,342 millions, company would post below average annual Net Income growth of 6.82% year on year, if the fiscal year would end at Jun 30 2024.
A slow-down in the Zoetis Inc 's Net Income growth from the 599% growth in Mar 31 2024.
In the Healthcare sector 53 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 339 to 620. |
| Net Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
141.59 % |
21.83 % |
-42.25 % |
|
|
|
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
141.59 % |
21.83 % |
-42.25 % |
|
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 12 |
| Sector |
# 52 |
| S&P 500 |
# 611 |
|
| Cumulative Net Income growth
Comment |
With the quarterly Net Income reported in the Jun 30 2024 period, Zoetis Inc 's cumulative twelve months Net Income were $ 2,342 millions, company would post below average annual Net Income growth of -42.25% year on year, if the fiscal year would end at Jun 30 2024.
A slow-down in the Zoetis Inc 's Net Income growth from the 599% growth in Mar 31 2024.
In the Healthcare sector 53 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 339 to 620. |
| Net Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
141.59 % |
21.83 % |
-42.25 % |
|
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
141.59 % |
21.83 % |
-42.25 % |
|
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 12 |
| Sector |
# 52 |
| S&P 500 |
# 611 |
|
